https://www.selleckchem.com/pr....oducts/tenalisib-rp6
BACKGROUND AND AIMS With rising rates of inflammatory bowel diseases (IBD) in older adults, management of co-morbidities such as osteoporosis is becoming increasingly important. Hip fracture (HF) is the most serious consequence of low bone mineral quality and is associated with excess risk of mortality. For older IBD patients, there are only limited data available. Therefore, we aimed to assess the association of IBD with HF and all-cause mortality risk after HF among IBD patients older than 50 years. METHODS In a national data